| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
ribonucleotide reductase regulatory subunit M2 | 0.555 | 0.769 | 0.30 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2019 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.846 | 2 | 0 | 1994 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.700 | None | 0.987 | 2 | 0 | 1989 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.920 | 2 | 0 | 1985 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.400 | None | 0.923 | 2 | 0 | 1997 | 2019 | ||||||||
|
solute carrier family 22 member 10 | 0.769 | 0.308 | 1.9E-19 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
tissue factor pathway inhibitor 2 | 0.521 | 0.769 | 8.4E-04 |
|
disease | 0.390 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.400 | None | 0.972 | 2 | 0 | 1997 | 2020 | ||||||||
|
follistatin | 0.513 | 0.731 | 0.98 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2002 | 2017 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 1979 | 2018 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
disease | 0.530 | None | 1.000 | 2 | 0 | 2000 | 2016 | ||||||||
|
phosphoenolpyruvate carboxykinase 1 | 0.608 | 0.538 | 8.7E-15 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
metallothionein 2A | 0.553 | 0.808 | 1.2E-05 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2007 | 2017 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.984 | 2 | 0 | 1996 | 2019 | ||||||||
|
sterol regulatory element binding transcription factor 1 | 0.518 | 0.808 | 1.5E-02 |
|
disease | 0.400 | None | 0.909 | 2 | 0 | 2004 | 2019 | ||||||||
|
metallothionein 1A | 0.537 | 0.808 | 4.5E-03 |
|
disease | 0.340 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.370 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
acyl-CoA oxidase 1 | 0.610 | 0.731 | 6.2E-02 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
disease | 0.400 | None | 0.941 | 2 | 0 | 1996 | 2019 | ||||||||
|
glyceraldehyde-3-phosphate dehydrogenase | 0.447 | 0.808 | 0.11 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1988 | 2019 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2003 | 2020 | ||||||||
|
growth differentiation factor 2 | 0.529 | 0.731 | 2.5E-03 |
|
disease | 0.320 | None | 0.750 | 2 | 0 | 2013 | 2017 |